BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8076905)

  • 1. The insulin-like growth factor I generation test: resistance to growth hormone with aging and estrogen replacement therapy.
    Lieberman SA; Mitchell AM; Marcus R; Hintz RL; Hoffman AR
    Horm Metab Res; 1994 May; 26(5):229-33. PubMed ID: 8076905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GH sensitivity of GH-deficient adults is dependent on gender but not timing of onset.
    Columb B; Smethurst LE; Mukherjee A; Jostel A; Shalet SM; Murray RD
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):281-6. PubMed ID: 18702681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.
    Christiansen JJ; Gravholt CH; Fisker S; Svenstrup B; Bennett P; Veldhuis J; Andersen M; Christiansen JS; Jørgensen JO
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):461-9. PubMed ID: 15049961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response.
    Florkowski CM; Barnard R; Livesey JH; Veveris T; Espiner EA; Donald RA
    Growth Horm IGF Res; 1999 Feb; 9(1):35-40. PubMed ID: 10207506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
    Weissberger AJ; Ho KK; Lazarus L
    J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
    Bellantoni MF; Harman SM; Cho DE; Blackman MR
    J Clin Endocrinol Metab; 1991 Jan; 72(1):172-8. PubMed ID: 1824707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The insulin-like growth factor I generation test in adults.
    Lissett CA; Gleeson H; Shalet SM
    Horm Res; 2004; 62 Suppl 1():44-9. PubMed ID: 15761232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The insulin-like growth factor-I generation test: peripheral responsiveness to growth hormone is not decreased with ageing.
    Lissett CA; Shalet SM
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):238-45. PubMed ID: 12580941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peak oxygen uptake, muscle volume, and the growth hormone-insulin-like growth factor-I axis in adolescent males.
    Eliakim A; Brasel JA; Barstow TJ; Mohan S; Cooper DM
    Med Sci Sports Exerc; 1998 Apr; 30(4):512-7. PubMed ID: 9565931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: the Rancho Bernardo Study.
    Goodman-Gruen D; Barrett-Connor E
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4268-71. PubMed ID: 8954026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ageing and longevity are related to growth hormone/insulin-like growth factor-1 secretion.
    Ruiz-Torres A; Soares de Melo Kirzner M
    Gerontology; 2002; 48(6):401-7. PubMed ID: 12393957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of IGF-I in muscular atrophy of aging.
    Borst SE; Lowenthal DT
    Endocrine; 1997 Aug; 7(1):61-3. PubMed ID: 9449034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone as therapy for older men and women.
    Marcus R; Hoffman AR
    Annu Rev Pharmacol Toxicol; 1998; 38():45-61. PubMed ID: 9597148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of growth hormone/insulin-like growth factor-I in polio survivors.
    Shetty KR; Rao UP; Gupta KL; Rudman D
    Ann N Y Acad Sci; 1995 May; 753():276-84. PubMed ID: 7611636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal therapy of intrinsic aging.
    Zouboulis CC; Makrantonaki E
    Rejuvenation Res; 2012 Jun; 15(3):302-12. PubMed ID: 22533363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of growth hormone and estrogen on T lymphocytes in older women.
    Bonello RS; Marcus R; Bloch D; Strober S
    J Am Geriatr Soc; 1996 Sep; 44(9):1038-42. PubMed ID: 8790227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal substitution in older men.
    Pugeat M; Fimbel S; Crave JC; Déchaud H; Lejeune H
    Horm Res; 1995; 43(1-3):104-10. PubMed ID: 7721255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging and immune function: a possible role for growth hormone.
    Gelato MC
    Horm Res; 1996; 45(1-2):46-9. PubMed ID: 8742118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.